Working… Menu

Cancer/Testis Antigen Immunotherapy Phase I Study With 740-CTA Vaccinia Virus (rVV-740CTA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03110445
Recruitment Status : Withdrawn (not sufficiently staff available to perform trial)
First Posted : April 12, 2017
Last Update Posted : February 7, 2020
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : September 2021
Estimated Study Completion Date : September 2021